Breiter Capital Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Breiter Capital Management’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$254K	Hold	1,700	–	–	0.13%	120
2021 Q4	$275K	Hold	1,700	–	–	0.13%	115
2021 Q3	$282K	Hold	1,700	–	–	0.16%	114
2021 Q2	$293K	Buy	+1,700	New	+$281K	0.16%	118
2021 Q1	–	Sell	-1,900	Closed	-$319K	–	70
2020 Q4	$319K	Hold	1,900	–	–	0.22%	95
2020 Q3	$299K	Hold	1,900	–	–	0.24%	83
2020 Q2	$319K	Hold	1,900	–	–	0.3%	77
2020 Q1	$249K	Buy	+1,900	New	+$271K	0.29%	85

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Breiter Capital Management's FBT Position: Q1 2022 in Review

Breiter Capital Management held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q1 2022 at 1,700 shares worth $254K. The position accounts for 0.13% of the portfolio, ranked #120.

Breiter Capital Management first reported a position in FBT in Q1 2020 and has held it in 8 quarters since. The position peaked at $319K in Q4 2020. 220 funds tracked by Wall St. Rank hold FBT as of Q1 2022.

Breiter Capital Management held 1,700 shares of First Trust NYSE Arca Biotechnology Index Fund worth $254K as of Q1 2022.
Breiter Capital Management left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q1 2022.
First Trust NYSE Arca Biotechnology Index Fund made up 0.13% of Breiter Capital Management's portfolio in Q1 2022, its #120 holding.
Breiter Capital Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2020 and has held it in 8 quarters since.
Breiter Capital Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $319K in Q4 2020.
220 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2022.

Based on Breiter Capital Management's 13F filing for Q1 2022, filed 11 May 2022.